
Daniel J Weisdorf MD
Professor, Medicine, University of Minnesota Medical School
Join to View Full Profile
516 Delaware Street SeMMC 480, PWB 14-110Minneapolis, MN 55455
Phone+1 612-624-3101
Fax+1 612-625-6919
Dr. Weisdorf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1978 - 1981
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1975 - 1978
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1975
Certifications & Licensure
ND State Medical License 2022 - 2027
MN State Medical License 1978 - 2026
IL State Medical License 1976 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma Start of enrollment: 2000 Aug 01
- Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma Start of enrollment: 2000 Aug 01
- Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease Start of enrollment: 2000 Jan 01
Publications & Presentations
PubMed
- Smoking cessation among blood or marrow transplant Survivors: a BMTSS Report.Nora Balas, Joshua Richman, Wendy Landier, Lindsey Hageman, Qingrui Meng
Bone Marrow Transplantation. 2025-10-01 - 2 citationsRisk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation: A Retrospective Center for Int...Meera Gupta, Michelle L Schoettler, Ruta Brazauskas, Stephanie Bo-Subait, Gabriel Orozco
Transplantation. 2025-10-01 - Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy.Hildegard T Greinix, Arthur Matas, Mickey B C Koh, Lydia Foeken, Nina Worel
Clinical Transplantation. 2025-10-01
Journal Articles
- Amphiregulin in Intestinal Acute Graft-Versus-Host Disease: A Possible Diagnostic and Prognostic AidBrittney Schultz, Bruce R Blazar, Daniel J Weisdorf, Shernan G Holtan, Alexander Khoruts, Armin Rashidi, Margaret L MacMillan, Khalid Amin, Byron P Vaughn, Nature
- Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated DonorsParameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
- Narrowing the Gap for Hematopoietic Stem Cell Transplantation in the East-Mediterranean/African Region: Comparison with Global HSCT Indications and TrendsMarcelo Pasquini, Daniel Weisdorf, Nature
Abstracts/Posters
- Impact of Depth of Pretransplant Clinical Response on Outcomes of Acute Myeloid Leukemia Patients in First Complete Remission (AML-CR1) Who Undergo Allogeneic Hematopo...Daniel J. Weisdorf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Burden of Long-Term Morbidity Borne By Survivors of Acute Myeloid Leukemia (AML) Treated with Blood or Marrow Transplantation (BMT) _ a Report from the BMT Survivor St...Daniel J. Weisdorf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Stroke Risk in Blood or Marrow Transplant (BMT) Survivors _ a Report from the BMT Survivor Study (BMTSS)Daniel J. Weisdorf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Validation of Minnesota Acute Gvhd Risk Score and Identification of New Factors Associated with Initial Response to Steroids: Not All Gvhd Is Created Equal2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Burden of Morbidity Borne By Survivors of Multiple Myeloma (MM) Treated with Autologous Blood or Marrow Transplant (BMT) - Results of the BMT Survivor Study (BMTSS)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Grant Support
- Enhancing The Safety Of Allogeneic TransplantationNational Heart, Lung, And Blood Institute2011
- Clinical Transplantation Exploiting NK Cell ActivityNational Cancer Institute2005–2011
- Enhanced GVHD Prophylaxis In Allogeneic Stem Cell TransplantationNational Heart, Lung, And Blood Institute2006–2010
- Mt2003-23:Non-Myeloblative Haploidentical HSCT With NK Cell Infusions In High RINational Center For Research Resources2007
- Non-Myeloblative Haploidentical HSCT With NK Cell Infusions In High Risk MyeloidNational Center For Research Resources2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









